Bone Cells and Bone Turnover in Diabetes Mellitus
- 6 March 2015
- journal article
- Published by Springer Nature in Current Osteoporosis Reports
- Vol. 13 (3) , 186-191
Abstract
Substantial evidence exists that in addition to the well-known complications of diabetes, increased fracture risk is an important morbidity. This risk is probably due, at least in part, to altered bone remodeling and bone cell function in diabetes. Circulating biochemical markers of bone formation, including P1NP, osteocalcin and bone-specific alkaline phosphatase have been found to be decreased in type 2 diabetes (T2D) and may be predictive of fractures independently of bone mineral density (BMD). These findings have been corroborated by preliminary histomorphometric data. Reductions in the bone resorption marker serum CTx in T2D have also been reported. Serum sclerostin levels have been found to be increased in T2D and appear to be predictive of fracture risk independent of BMD. Other factors such as bone marrow fat saturation, advanced glycation endproduct (AGE) accumulation, and microarchitectural changes might also relate to bone cell function and fracture risk in diabetes.Keywords
This publication has 57 references indexed in Scilit:
- Circulating Sclerostin Associated With Vertebral Bone Marrow Fat in Older Men But Not WomenThe Journal of Clinical Endocrinology & Metabolism, 2014
- Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fracturesJournal of Bone and Mineral Research, 2013
- Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research DatabaseActa Orthopaedica, 2012
- FRAX underestimates fracture risk in patients with diabetesJournal of Bone and Mineral Research, 2011
- Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogsOsteoporosis International, 2008
- The role of the collagen matrix in skeletal fragilityCurrent Osteoporosis Reports, 2007
- Characterization of circulating osteoblast lineage cells in humansBone, 2007
- Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-γ2 Expression in Type I Diabetic MiceEndocrinology, 2005
- Fructose‐mediated non‐enzymatic glycation: sweet coupling or bad modificationDiabetes/Metabolism Research and Reviews, 2004
- Accelerated age-related browning of human collagen in diabetes mellitus.Proceedings of the National Academy of Sciences, 1984